$88.72
At close: Mar 21, 4:00 PM EDT
$88.72
0.000.00%
After Hours: Mar 21, 4:00 PM EDT
Blueprint Medicines issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
01/05/2023 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $200.00M | $200.00M | $199.69M | Get Alert |
11/01/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $200.00M | $200.00M | $191.21M | Get Alert |
08/02/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $194.85M | Get Alert |
05/03/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $192.34M | Get Alert |
02/16/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $210.91M | Get Alert |
01/10/2022 | BPMC | Blueprint Medicines | FY | 2021 | — | — | — | $180.00M | $180.00M | $173.16M | Get Alert |
10/28/2021 | BPMC | Blueprint Medicines | FY | 2021 | — | — | — | $170.00M | $180.00M | $148.37M | Get Alert |
There have been no specific sales or earnings guidance reported for Blueprint Medicines in recent months.
Browse guidance and forecast on all stocks.